Non categorizzato BioNTech sees $3.3B revenue for 2024, expanding into oncology Gennaio 9, 2024 0 commenti BioNTech, the company known for developing the COVID-19 vaccine with Pfizer, expects revenues in 2024 to be around €3 billion, it said in a statement on Tuesday. The forecast is part of the compa… About the author:
Get involved!
Comments